Sanofi (SNY) Equity Ratio (2009 - 2025)

Sanofi has disclosed Equity Ratio across 17 years of filings, most recently posting 0.56 for Q4 2025.

• Equity Ratio for Q4 2025 came in at 0.56, down 3.56% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.56 (down 3.56% YoY), and the FY2025 annual result was 0.56, down 3.56% from the prior year.
• Equity Ratio came in at 0.56 for Q4 2025 at Sanofi, roughly flat from 0.56 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.59 in Q4 2022 to a low of 0.56 in Q2 2025.
• The 5-year median for Equity Ratio is 0.58 (2021), against an average of 0.57.
• Across the five-year window, Equity Ratio tumbled 98.55% in 2021 and advanced 3.96% in 2022, its largest moves.
• Sanofi's Equity Ratio stood at 0.57 in 2021, then climbed by 3.32% to 0.59 in 2022, then retreated by 0.79% to 0.59 in 2023, then declined by 0.31% to 0.58 in 2024, then declined by 3.56% to 0.56 in 2025.
• The last three Equity Ratio figures came in at 0.56 (Q4 2025), 0.56 (Q2 2025), and 0.58 (Q4 2024), per Business Quant data.